The clinical effect of teriparatide on BRONJ (bisphosphonate-related osteonecrosis of the jaw)
- Conditions
- bisphosphonate-related osteonecrosis of the jaw
- Registration Number
- JPRN-UMIN000042862
- Lead Sponsor
- Kyushu Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Not provided
Patients with hypercalcemia Patients who are considered to be at high risk of developing osteosarcoma as follows (a) Patients with Paget's disease of bone (b) Patients with unexplained high alkaline phosphatase levels (c) Young patients whose epiphyseal line has not yet closed (d) Patients who have received radiation therapy that may affect bone in the past. Patients with primary malignant bone tumors or metastatic bone tumors Patients with metabolic bone diseases other than osteoporosis (hyperparathyroidism, etc.) Pregnant women, women who may become pregnant, and lactating women Patients with a history of hypersensitivity to teriparatide components or teriparatide acetate Patients with serious complications such as cancer, cardiac disease, liver disease, and renal disorder Patients currently using an activated vitamin D preparation or a digitalis preparation Patients who are unable to give informed consent Patients who are judged by the physician to be unsuitable for teriparatide treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method